Minimum Residual Disease in Acute Lymphoblastic Leukemia
5 意见
administrator
08/04/23
In this segment, Jeffrey Lancet, MD; Raoul Tibes, MD; and Mark R. Litzow, MD, describe various methodologies in monitoring minimum residual disease in acute lymphoblastic leukemia.
显示更多
脸书评论
没有找到评论